Nanjing Pharmaceutical Co. Ltd.
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Nanjing Pharmaceutical Co. Ltd.
Multinationals Look To M&A As Key China Growth Driver
Mergers and acquisitions have been highlighted as key drivers of growth for pharma companies in China as domestic companies look to expand globally and multinationals attempt to localize.
Asia On The Move: Xian Janssen China President Thad Huston Leaves
The change of seasons coincides with a flurry of key personnel moves in the Asian pharmaceutical scene. Xian Janssen China President Thad Huston moves up, Simcere vice president Jie Liu D’Elia joins BMS. Personnel changes also took place in Takeda, Lupin, inVentive Health and the Japan Pharmaceutical Manufacturers Association.
Asia On The Move: Alliance Boots Partner Nanjing Pharma President Quits, BIO’s EVP Leaves For Celgene
Nanjing Pharma has seen three top executive departures in recent months, which could impact its collaboration with U.K. pharmacy giant Alliance Boots. Meanwhile, personnel changes also took place at BIO, Mundipharma, Beigene, Catalent Pharma Solutions and Zhejiang FDA.
Asia On The Move: Alliance Boots Partner Nanjing Pharma President Quits, BIO’s EVP Leaves For Celgene
Nanjing Pharma has seen three top executive departures in recent months, which could impact its collaboration with U.K. pharmacy giant Alliance Boots. Meanwhile, personnel changes also took place at BIO, Mundipharma, Beigene, Catalent Pharma Solutions and Zhejiang FDA.
Company Information
- Industry
- Medical Devices
- Services
-
Pharmaceuticals
- OTC, Consumer
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice